Tempus Unveils AI-Enabled Smart Tests Across Disease Types

Tempus Unveils AI-Enabled Smart Tests Across Disease Types

NEWS

January 20, 2020

Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, unveils its AI-enabled laboratory test (smart test) platform. Through its technology, laboratory tests are now able to be embedded with real-world evidence that deliver real-time, actionable insights to physicians, providing critical information about the right treatments, for the right patients, at the right time.

Tempus is ushering in the age of precision medicine with a proprietary platform that ingests data across all major disease types and analyzes data points to derive personalized insights. In connecting medical test results to phenotypic, morphologic, and molecular data, including real-time outcome data from electronic health records (EHR) that is longitudinally updated, Tempus is able to add clinical context to physician-ordered laboratory tests. Ultimately, these smart lab tests employ AI to identify optimal therapeutic options for each patient.

“Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way,” said Eric Lefkofsky, Founder and CEO of Tempus. “Our goal is to make every laboratory test in the world smarter, by connecting results to clinical data about the patient and other patients who are similarly afflicted; providing clinicians with seamless access to real-world data and insights that will increasingly personalize care across all diseases.”

Tempus has successfully implemented this strategy in oncology, leveraging its smart, broad-panel genomic tests to identify therapeutic options specific to each cancer patient. Last year, Tempus announced its plans to expand into other disease areas—including depression and cardiology—whereby it will append blood tests and EKG’s with multi-modal data, thereby augmenting the utility of the test result. These smart tests are only possible as a result of the aggregation of clinical data at scale.

About Tempus
Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and analyze molecular and therapeutic data to empower physicians and researchers to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing the health care industry with tools that learn as we gather more data. For more information, visit tempus.com.